- Home
- INBK vs GNLX Comparison
INBK vs GNLX Comparison
Compare INBK & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- GNLX
- Stock Information
- Founded
- INBK 1999
- GNLX 2001
- Country
- INBK United States
- GNLX United States
- Employees
- INBK N/A
- GNLX 24
- Industry
- INBK Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- GNLX Health Care
- Exchange
- INBK Nasdaq
- GNLX Nasdaq
- Market Cap
- INBK 190.0M
- GNLX 202.4M
- IPO Year
- INBK N/A
- GNLX 2023
- Fundamental
- Price
- INBK $17.95
- GNLX $5.36
- Analyst Decision
- INBK Hold
- GNLX Strong Buy
- Analyst Count
- INBK 3
- GNLX 4
- Target Price
- INBK $28.67
- GNLX $19.75
- AVG Volume (30 Days)
- INBK 85.5K
- GNLX 354.5K
- Earning Date
- INBK 10-22-2025
- GNLX 11-05-2025
- Dividend Yield
- INBK 1.33%
- GNLX N/A
- EPS Growth
- INBK N/A
- GNLX N/A
- EPS
- INBK N/A
- GNLX N/A
- Revenue
- INBK $46,731,000.00
- GNLX N/A
- Revenue This Year
- INBK $4.47
- GNLX N/A
- Revenue Next Year
- INBK $25.08
- GNLX N/A
- P/E Ratio
- INBK N/A
- GNLX N/A
- Revenue Growth
- INBK N/A
- GNLX N/A
- 52 Week Low
- INBK $17.30
- GNLX $1.99
- 52 Week High
- INBK $43.27
- GNLX $8.54
- Technical
- Relative Strength Index (RSI)
- INBK 35.33
- GNLX 41.11
- Support Level
- INBK $17.30
- GNLX $4.34
- Resistance Level
- INBK $18.59
- GNLX $6.26
- Average True Range (ATR)
- INBK 0.74
- GNLX 0.82
- MACD
- INBK 0.13
- GNLX -0.34
- Stochastic Oscillator
- INBK 32.56
- GNLX 23.88
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.